Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–5 of 5 results
Advanced filters: Author: "E Williams" Clear advanced filters
  • For most actors sustained productivity defines success. Here the authors study the careers of actors and identify a "rich-get-richer" mechanism with respect to productivity, the emergence of hot streaks and the presence of gender bias, and are able to predict whether the most productive year of an actor is yet to come.

    • Oliver E. Williams
    • Lucas Lacasa
    • Vito Latora
    ResearchOpen Access
    Nature Communications
    Volume: 10, P: 1-8
  • Currently, the anti-CD20 monoclonal antibody ocrelizumab is the only approved treatment for primary progressive multiple sclerosis (PPMS). However, a new study suggests that other immunomodulatory disease-modifying therapies that are often used to treat relapsing forms of multiple sclerosis could be effective in people with PPMS who have evidence of active inflammatory disease.

    • Thomas Williams
    • Jeremy Chataway
    News & Views
    Nature Reviews Neurology
    Volume: 18, P: 641-642